The study of Golgi apparatus in Alzheimer's disease

被引:28
作者
Hu, Zhiping [1 ]
Zeng, Liuwang [1 ]
Huang, Zhiling [1 ]
Zhang, Jie [1 ]
Li, Ting [1 ]
机构
[1] Cent S Univ, Xiangya Hosp 2, Dept Neurol, Changsha 410011, Peoples R China
关键词
Golgi apparatus; Alzheimer's disease; amyloid beta-protein; amyloid precursor protein; presenilins; gamma-secretase; tau;
D O I
10.1007/s11064-007-9302-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alzheimer's disease is an irreversible, progressive neurodegenerative disorder leading invariably to death, usually within 7-10 years after diagnosis and is the leading cause of dementia in the elderly. Not only is Alzheimer's disease a tragic disease in which people suffer from neurodegeneration in the years to come, it also becomes an incredible burden on the public health system. However, there is currently no effective treatment to halt the progression or prevent the onset of Alzheimer's disease. This is partly due to the fact that the complex pathophysiology of Alzheimer's disease is not yet completely understood. Recently, Golgi apparatus is found to play an important role in Alzheimer's disease. In this review, we discuss the changes of Golgi apparatus during clinical progression and pathological development of Alzheimer's disease. First, changes of Golgi apparatus size in Alzheimer's disease are summarized. We then address the role of Golgi apparatus in the neuropathology of Alzheimer's disease. Finally, the role of Golgi apparatus in the pathogenesis of Alzheimer's disease is discussed. Understanding the contribution of Golgi apparatus dysfunction to Alzheimer's disease and its pathophysiological basis will significantly impact our ability to develop more effective therapies for Alzheimer's disease.
引用
收藏
页码:1265 / 1277
页数:13
相关论文
共 92 条
[1]   Molecular dissection of the interaction between amyloid precursor protein and its neuronal trafficking receptor SorLA/LR11 [J].
Andersen, OM ;
Schmidt, V ;
Spoelgen, R ;
Gliemann, J ;
Behlke, J ;
Galatis, D ;
McKinstry, WJ ;
Parker, MW ;
Masters, CL ;
Hyman, BT ;
Cappai, R ;
Willnow, TE .
BIOCHEMISTRY, 2006, 45 (08) :2618-2628
[2]  
Anderson M, 2002, FILM COMMENT, V38, P6
[3]   Presenilin 1 controls γ-secretase processing of amyloid precursor protein in pre-Golgi compartments of hippocampal neurons [J].
Annaert, WG ;
Levesque, L ;
Craessaerts, K ;
Dierinck, I ;
Snellings, G ;
Westaway, D ;
George-Hyslop, PS ;
Cordell, B ;
Fraser, P ;
De Strooper, B .
JOURNAL OF CELL BIOLOGY, 1999, 147 (02) :277-294
[4]   Functional γ-secretase complex assembly in Golgi/trans-Golgi network:: interactions among presenilin, nicastrin, Aph1, Pen-2, and γ-secretase substrates [J].
Baulac, S ;
LaVoie, MJ ;
Kimberly, WT ;
Strahle, J ;
Wolfe, MS ;
Selkoe, DJ ;
Xia, WM .
NEUROBIOLOGY OF DISEASE, 2003, 14 (02) :194-204
[5]  
Biederer T, 2002, J NEUROSCI, V22, P7340
[6]   Presenilin-1 uses phospholipase D1 as a negative regulator of β-amyloid formation [J].
Cai, DM ;
Netzer, WJ ;
Zhong, MH ;
Lin, YX ;
Du, GW ;
Frohman, M ;
Foster, DA ;
Sisodia, SS ;
Xu, HX ;
Gorelick, FS ;
Greengard, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (06) :1941-1946
[7]   Phospholipase D1 corrects impaired βAPP trafficking and neurite outgrowth in familial Alzheimer's disease-linked presenilin-1 mutant neurons [J].
Cai, DM ;
Zhong, MH ;
Wang, RS ;
Netzer, WJ ;
Shields, D ;
Zheng, H ;
Sisodia, SS ;
Foster, DA ;
Gorelick, FS ;
Xu, HX ;
Greengard, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (06) :1936-1940
[8]   Presenilin-1 regulates intracellular trafficking and cell surface delivery of β-amyloid precursor protein [J].
Cai, DM ;
Leem, JY ;
Greenfield, JP ;
Wang, P ;
Kim, BS ;
Wang, RS ;
Lopes, KO ;
Kim, SH ;
Zheng, H ;
Greengard, P ;
Sisodia, SS ;
Thinakaran, G ;
Xu, HX .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (05) :3446-3454
[9]   Endoproteolysis of presenilin in vitro:: Inhibition by γ-secretase inhibitors [J].
Campbell, WA ;
Iskandar, MK ;
Reed, MLO ;
Xia, WM .
BIOCHEMISTRY, 2002, 41 (10) :3372-3379
[10]   Factors influencing the processing and function of the amyloid β precursor protein -: a potential therapeutic target in Alzheimer's disease? [J].
Coughlan, CM ;
Breen, KC .
PHARMACOLOGY & THERAPEUTICS, 2000, 86 (02) :111-144